AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Spencer Pharmaceutical Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
29.44K
AVG Volume
231
Trailing/Forward PE
-0/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
0500K1M1.5M02 Q102 Q202 Q302 Q403 Q103 Q203 Q303 Q404 Q1
SPPH Revenue (USD) by quarter
PeriodRevenue (USD)
04 Q1670.21K
03 Q40
03 Q30
03 Q20
03 Q10
02 Q41.33M
02 Q3430.53K
02 Q2441.76K
02 Q1425.58K
Net Income (USD)
-1M-500K0500K02 Q102 Q202 Q302 Q403 Q103 Q203 Q303 Q404 Q1
SPPH Net Income (USD) by quarter
PeriodNet Income (USD)
04 Q1-509.69K
03 Q4-517.62K
03 Q3-54.45K
03 Q2-155.67K
03 Q1-134.8K
02 Q4134.5K
02 Q3-527.86K
02 Q2-969.54K
02 Q1-876.74K
Operating Income (USD)
-500K0500K1M02 Q102 Q202 Q302 Q403 Q103 Q203 Q303 Q404 Q1
SPPH Operating Income (USD) by quarter
PeriodOperating Income (USD)
04 Q1494.81K
03 Q4783.81K
03 Q354.45K
03 Q2891
03 Q1133.94K
02 Q4-129.82K
02 Q3547.13K
02 Q2182.24K
02 Q1882.72K
EBITDA (USD)
-1M-500K0500K02 Q102 Q202 Q302 Q403 Q103 Q203 Q303 Q404 Q1
SPPH EBITDA (USD) by quarter
PeriodEBITDA (USD)
04 Q1-460.66K
03 Q4-783.81K
03 Q3-54.45K
03 Q2-891
03 Q1-131.31K
02 Q4141.17K
02 Q3-536.22K
02 Q2-175.77K
02 Q1-862.55K
Cash Flows (USD)
-1.5M-1M-500K0500K1M02 Q102 Q202 Q302 Q403 Q103 Q203 Q303 Q404 Q1
SPPH Cash Flows (USD) by quarter
PeriodCash Flows (USD)
04 Q1-82.67K
03 Q4647.76K
03 Q3-1.04M
03 Q2-159.86K
03 Q1-216.88K
02 Q4-361.57K
02 Q3-392.42K
02 Q2-1.09M
02 Q1-837.39K
EPS (USD)
-1.5-1-0.500.502 Q102 Q202 Q302 Q403 Q103 Q203 Q303 Q404 Q1
SPPH EPS (USD) by quarter
PeriodEPS (USD)
04 Q1-0.5
03 Q4-0.5
03 Q3-0.09
03 Q2-0.25
03 Q1-0.25
02 Q40.18
02 Q3-0.75
02 Q2-1.25
02 Q1-1.25
Expenses (USD)
0500K1M1.5MR&DSG&ACapex02 Q102 Q202 Q302 Q403 Q103 Q203 Q303 Q404 Q1
SPPH Expenses (USD) by quarter
PeriodExpenses (USD)
04 Q1556.12K
03 Q4522.94K
03 Q354.45K
03 Q2891
03 Q1131.31K
02 Q41.19M
02 Q3977.42K
02 Q21.41M
02 Q11.32M
Cash & Debt (USD)
01M2M3MCashShort Term Debt02 Q102 Q202 Q302 Q403 Q103 Q203 Q303 Q404 Q1
SPPH Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
04 Q12.83K
03 Q421.09K
03 Q3586.91K
03 Q227.44K
03 Q187.3K
02 Q4304.18K
02 Q3665.75K
02 Q21.03M
02 Q12.12M
Debt ratios
-505101502 Q403 Q103 Q203 Q303 Q404 Q1
SPPH Debt ratios by quarter
PeriodDebt ratios
04 Q1-0.41
03 Q4-0.14
03 Q312.9
03 Q20.05
03 Q10.12
02 Q40.21
Margins
0%25%50%75%100%02 Q102 Q202 Q302 Q404 Q1
SPPH Margins by quarter
PeriodMargins
04 Q113.44%
02 Q4100%
02 Q3100%
02 Q2100%
02 Q1100%
Return on Capital
-1000%0%1000%2000%3000%02 Q102 Q202 Q302 Q403 Q103 Q203 Q303 Q404 Q1
SPPH Return on Capital by quarter
PeriodReturn on Capital
04 Q1-13.28%
03 Q4-13.41%
03 Q3-1.74%
03 Q2835.22%
03 Q124.29%
02 Q4-32.01%
02 Q393.76%
02 Q22231.04%
02 Q1-95.07%
Shares Outstanding
0500K1M1.5M02 Q102 Q202 Q302 Q403 Q103 Q203 Q303 Q404 Q1
SPPH Shares Outstanding by quarter
PeriodShares Outstanding
04 Q11.3M
03 Q41.04M
03 Q3618.57K
03 Q2602.16K
03 Q1747.17K
02 Q4746.29K
02 Q3747.17K
02 Q2747.17K
02 Q1739.62K
Book Value Per Share (USD)
-2024602 Q102 Q202 Q302 Q403 Q103 Q203 Q303 Q404 Q1
SPPH Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
04 Q12.96
03 Q43.71
03 Q35.05
03 Q2-0.03
03 Q1-0.74
02 Q4-0.56
02 Q3-0.75
02 Q2-0.06
02 Q11.25
Total Assets (USD)
02M4M6M02 Q102 Q202 Q302 Q403 Q103 Q203 Q303 Q404 Q1
SPPH Total Assets (USD) by quarter
PeriodTotal Assets (USD)
04 Q15.61M
03 Q44.24M
03 Q33.18M
03 Q227.44K
03 Q1159.66K
02 Q4419.24K
02 Q3735.41K
02 Q21.49M
02 Q12.56M
Free Cash Flow Yield
-60000000%-40000000%-20000000%0%med -489824.26%Jan 25May 25Sep 25Jan 26May 26Sep 26
SPPH Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-489824.26%
Sep 26-489824.26%
Aug 26-489824.26%
Aug 26-489824.26%
Aug 26-489824.26%
Aug 26-489824.26%
Jul 26-489824.26%
Jul 26-489824.26%
Jul 26-489824.26%
Jul 26-489824.26%
Jul 26-489824.26%
Jun 26-489824.26%
Jun 26-489824.26%
Jun 26-489824.26%
Jun 26-489824.26%
May 26-489824.26%
May 26-489824.26%
May 26-489824.26%
May 26-489824.26%
May 26-489824.26%
Apr 26-489824.26%
Apr 26-489824.26%
Apr 26-489824.26%
Apr 26-489824.26%
Mar 26-489824.26%
Mar 26-489824.26%
Mar 26-489824.26%
Mar 26-489824.26%
Feb 26-489824.26%
Feb 26-489824.26%
Feb 26-489824.26%
Feb 26-489824.26%
Jan 26-489824.26%
Jan 26-489824.26%
Jan 26-489824.26%
Jan 26-489824.26%
Jan 26-489824.26%
Dec 25-489824.26%
Dec 25-489824.26%
Dec 25-489824.26%
Dec 25-489824.26%
Nov 25-489824.26%
Nov 25-489824.26%
Nov 25-489824.26%
Nov 25-489824.26%
Oct 25-489824.26%
Oct 25-489824.26%
Oct 25-489824.26%
Oct 25-489824.26%
Oct 25-489824.26%
Sep 25-489824.26%
Sep 25-489824.26%
Sep 25-489824.26%
Sep 25-489824.26%
Aug 25-489824.26%
Aug 25-489824.26%
Aug 25-489824.26%
Aug 25-489824.26%
Aug 25-489824.26%
Jul 25-489824.26%
Jul 25-489824.26%
Jul 25-489824.26%
Jul 25-489824.26%
Jun 25-489824.26%
Jun 25-489824.26%
Jun 25-489824.26%
Jun 25-489824.26%
May 25-489824.26%
May 25-489824.26%
May 25-489824.26%
May 25-489824.26%
May 25-489824.26%
Apr 25-489824.26%
Apr 25-48982424.11%
Apr 25-489824.26%
Apr 25-489824.26%
Mar 25-489824.26%
Mar 25-489824.26%
Mar 25-489824.26%
Mar 25-489824.26%
Feb 25-489824.26%
Feb 25-489824.26%
Feb 25-489824.26%
Feb 25-489824.26%
Jan 25-489824.26%
Jan 25-489824.26%
Jan 25-489824.26%
Jan 25-489824.26%
Jan 25-489824.26%
Dec 24-489824.26%
Dec 24-489824.26%
Dec 24-489824.26%
Dec 24-489824.26%
Nov 24-489824.26%
Nov 24-489824.26%
Nov 24-489824.26%
Nov 24-489824.26%
Nov 24-489824.26%
Oct 24-489824.26%
Oct 24-489824.26%
Price to Sales
00000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SPPH Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
Price to Book
00000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SPPH Price to Book by quarter
PeriodPrice to Book
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
Spencer Pharmaceutical Inc.
SPPH
Stockpicker

Video analysis: SPPH

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.